Conference call with CEO Cubo and Dr. Craig McDonald to discuss gene therapy for DMD on February 9 at 11 am hosted b William Blair.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLDB:
- Solid Biosciences participates in a conference call with Cantor
- Solid Biosciences: Leveraging Next-Generation Gene Therapy in DMD to Support a Buy-Rated Risk-Reward Profile
- Solid Biosciences: Advancing DMD Gene Therapy Toward 2026 Value Inflection With Accelerated Approval Potential
- FDA grants Solid Biosciences orphan drug designation for SGT-212
- Solid Biosciences doses first participant in Phase 1b FALCON trial on SGT-212